Nicole LaBrosse - 16 Feb 2026 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
16 Feb 2026
Net transactions value
-$1,024,299
Form type
4
Filing time
17 Feb 2026, 18:52:46 UTC
Previous filing
11 Feb 2026
Next filing
24 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO /s/ James R. Oehler, Attorney-in-Fact 17 Feb 2026 0001910662

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +5,093 +23% $0.000000 27,172 16 Feb 2026 Direct
transaction HALO Common Stock Tax liability $218,222 -2,747 -10% $79.44 24,425 16 Feb 2026 Direct F1
transaction HALO Common Stock Options Exercise $0 +5,329 +22% $0.000000 29,754 16 Feb 2026 Direct
transaction HALO Common Stock Tax liability $228,311 -2,874 -9.7% $79.44 26,880 16 Feb 2026 Direct F2
transaction HALO Common Stock Options Exercise $0 +13,351 +50% $0.000000 40,231 16 Feb 2026 Direct
transaction HALO Common Stock Tax liability $577,767 -7,273 -18% $79.44 32,958 16 Feb 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -5,093 -100% $0.000000 0 16 Feb 2026 Common Stock 5,093 $0.000000 Direct F4
transaction HALO Restricted Stock Units Options Exercise $0 -5,329 -50% $0.000000 5,329 16 Feb 2026 Common Stock 5,329 $0.000000 Direct F4
transaction HALO Performance Stock Units Options Exercise $0 -13,351 -100% $0.000000 0 16 Feb 2026 Common Stock 13,351 $0.000000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 2,747 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 The reported disposition of 2,874 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 The reported disposition of 7,273 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F4 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
F5 This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.